Free provider profile

MIREYA WESSOLOSSKY, M.D.

NPI 1083604474
Individual
Internal Medicine, Infectious Disease
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like MIREYA WESSOLOSSKY?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What MIREYA WESSOLOSSKY prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Biktarvy
  • Genvoya
  • Triumeq
  • Odefsey
  • Juluca

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

774-441-8230

Practice address

55 LAKE AVE N, WORCESTER, MA, 01655

Registry updated
2026-10-27
NPI issued
2005-10-26
RepVector retrieved
11/21/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

55 LAKE AVE N, WORCESTER, MA, 01655

774-441-8230

5 practice locations listed

Enumerated 2005-10-26

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — 5 practice locations listed — multi-site footprint.
  • — Record updated within the last year.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

1,251

Medicare patients

102

Part D drug cost

$2,429,881

Brand-name share

59.7%

of this prescriber's Part D claims

DrugClaimsMedicare cost
Biktarvy (Bictegrav/Emtricit/Tenofov Ala)204$804,803
Genvoya (Elviteg/Cob/Emtri/Tenof Alafen)146$585,573
Triumeq (Abacavir/Dolutegravir/Lamivudi)99$357,658
Odefsey (Emtricitab/Rilpiviri/Tenof Ala)61$222,874
Juluca (Dolutegravir/Rilpivirine)34$110,436
Dovato (Dolutegravir Sodium/Lamivudine)25$71,240
Prezcobix (Darunavir/Cobicistat)24$55,056
Tivicay (Dolutegravir Sodium)21$54,249

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across MA — which companies pay providers there.

Open Payments page for this provider

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.